Background: Programmed cell death protein 1 (PD-1) blocking monoclonal antibodies improve the overall survival of patients with advanced melanoma but the optimal duration of treatment has not been established. Patients and Methods: This academic real-world cohort study investigated the outcome of 185 advanced melanoma patients who electively discontinued anti-PD-1 therapy with pembrolizumab (N ¼ 167) or nivolumab (N ¼ 18) in the absence of disease progression (PD) or treatment limiting toxicity (TLT) at 14 medical centres across Europe and Australia. Results: Median time on treatment was 12 months (range 0.7-43). The best objective tumour response at the time of treatment discontinuation was complete response (CR) in 117 (63%) patients, partial response (PR) in 44 (24%) patients and stable disease (SD) in 16 (9%) patients; 8 (4%) patients had no evaluable disease (NE). After a median follow-up of 18 months (range 0.7-48) after treatment discontinuation, 78% of patients remained free of progression. Median time to progression was 12 months (range 2-23). PD was less frequent in patients with CR (14%) compared with patients with PR (32%) and SD (50%). Six out of 19 (32%) patients who were retreated with an anti-PD-1 at the time of PD obtained a new antitumour response. Conclusions: In this real-world cohort of advanced melanoma patients discontinuing anti-PD-1 therapy in the absence of TLT or PD, the duration of anti-PD-1 therapy was shorter when compared with clinical trials. In patients obtaining a CR, and being treated for >6 months, the risk of relapse after treatment discontinuation was low. Patients achieving a PR or SD as best tumour response were at higher risk for progression after discontinuing therapy, and defining optimal treatment duration in such patients deserves further study. Retreatment with an anti-PD-1 at the time of progression may lead to renewed antitumour activity in some patients.
• Changes in CT body composition occur after neoadjuvant chemotherapy in oesophageal cancer. • Sarcopenia was more prevalent after neoadjuvant chemotherapy. • Fat mass, fat-free mass and weight decreased after neoadjuvant chemotherapy. • Changes in body composition were associated with CRM positivity. • Changes in body composition did not affect perioperative complications and survival.
The research proposes a model, which relates the following variables: (a) the CEO's perceptions of the environment, (b) the strategic business orientation, scanning, and structural characteristics, (c) technology policy, (d) realized innovative efforts of the firm, and (e) measures of firm performance. The empirical data from small manufacturing enterprises (SMEs) that share a common economic and industrial environment show that CEOs' perceptions of external environment---and not objective measures---are key significant issues with respect to technology policy formulation and enactment in SMEs and its subsequent organizational impacts. In particular, perceived environmental hostility and dynamism are shown to have specific and differing moderating roles on the form and strength of the relationships between technology policy and its determinants and between technology policy and realized innovative efforts. Furthermore, a more aggressive technology policy leads to greater realized innovative efforts, which in turn are positively related to export performance and, to a lesser extent, to financial performance.strategic management of technology, small firms, strategy enactment, perceptions of the external environment
In 1996, Schwartz, Dockery, and Neas 1 reported that daily mortality was more strongly associated with concentrations of PM 2.5 than with concentrations of larger particles (coarse mass [CM]) in six U.S. cities ("original paper"/"original analyses"). Because of the public policy implications of the findings and the uniqueness of the concentration data, we undertook a reanalysis of these results. This paper presents results of the reconstruction of these data and replication of the original analyses using the reconstructed data. The original investigators provided particulate air pollution data for this paper. Daily weather and daily counts of total and causespecific deaths were reconstructed from original public records. The reconstructed particulate air pollution and weather data were consistent with the summaries presented in the original paper. Daily counts of deaths in the reconstructed data set were lower than in the original paper because of restrictions on residence and place of death. The reconstruction process identified an administrative change in county codes that led to higher
IMPLICATIONSThe reported association of daily mortality with fine particles has been cited as central in the debate over control of particulate air pollution. Replication of results and validation of data and methods are cornerstones of scientific inquiry. This data reconstruction and reanalysis using the reconstructed data produced results similar to those presented in the original publication important to that debate. Validation of the original Schwartz, Dockery, and Neas 1 findings would require replication and analyses of independently constructed datasets and procedures.numbers of deaths in St. Louis. Despite these differences in daily counts of deaths, the estimated effects of particulate air pollution from the reconstructed dataset, using analytic methods as described in the original paper, produced combined effect estimates essentially equivalent to the originally published results. For example, the estimated association of a 10 µg/m 3 increase in 2-day mean particulate air pollution on total mortality was 1.3% (95% confidence interval [CI] 0.9-1.7%, t = 6.53) for PM 2.5 based on the reconstructed dataset, compared to the originally reported association of 1.5% (95% CI 1.1-1.9%, t = 7.41). For coarse particles, the estimated association from the reconstructed dataset was 0.4% (95% CI -0.2-0.9%, t = 1.43) compared to the originally reported association of 0.4% (95% CI -0.1-1.0%, t = 1.48). These results from the reconstructed data suggest that the original results reported by Schwartz, Dockery, and Neas 1 were essentially replicated.
The Boston Marathon bombing story unfolded on every possible carrier of information available in the spring of 2013, including Twitter. As information spread, it was filled with rumors (unsubstantiated information), and many of these rumors contained misinformation. Earlier studies have suggested that crowdsourced information flows can correct misinformation, and our research investigates this proposition. This exploratory research examines three rumors, later demonstrated to be false, that circulated on Twitter in the aftermath of the bombings. Our findings suggest that corrections to the misinformation emerge but are muted compared with the propagation of the misinformation. The similarities and differences we observe in the patterns of the misinformation and corrections contained within the stream over the days that followed the attacks suggest directions for possible research strategies to automatically detect misinformation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.